Tag: <span>cancer trials</span>

Home / cancer trials
Post

Drugs showing promise in cancer trials reduce scarring for scleroderma

Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, an incurable and life-threatening autoimmune disease, a new study shows. Scleroderma is a chronic disease that affects the immune system, causing a buildup of scar-like tissues in the skin and internal organs known as fibrosis. This process...